HealthEquity (NASDAQ:HQY) Updates FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 3.870-3.950 for the period, compared to the consensus EPS estimate of 3.690. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Wall Street Analyst Weigh In

HQY has been the topic of a number of research analyst reports. Barrington Research reiterated an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. UBS Group set a $110.00 price target on HealthEquity in a research note on Tuesday. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Monday, January 19th. The Goldman Sachs Group downgraded shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price for the company. in a report on Friday, January 9th. Finally, Barclays reaffirmed an “overweight” rating and issued a $110.00 price target on shares of HealthEquity in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $115.60.

HealthEquity Price Performance

HQY stock opened at $74.36 on Wednesday. The stock has a market capitalization of $6.35 billion, a price-to-earnings ratio of 34.11, a price-to-earnings-growth ratio of 0.92 and a beta of 0.24. The stock’s fifty day simple moving average is $87.65 and its 200-day simple moving average is $91.95. HealthEquity has a 52-week low of $72.76 and a 52-week high of $116.65. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period last year, the company earned $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts expect that HealthEquity will post 2.32 EPS for the current year.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president directly owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,959 shares of company stock valued at $1,344,957 in the last ninety days. 1.50% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HealthEquity

Several institutional investors and hedge funds have recently modified their holdings of HQY. Acumen Wealth Advisors LLC purchased a new stake in shares of HealthEquity during the 4th quarter valued at about $27,000. Aster Capital Management DIFC Ltd acquired a new stake in HealthEquity in the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd grew its position in HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of HealthEquity by 190.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after purchasing an additional 396 shares during the period. Finally, Larson Financial Group LLC lifted its position in shares of HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after purchasing an additional 123 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.